Am J Perinatol
DOI: 10.1055/a-2442-7305
Review Article

Hypoglycemia in Pregnant Women with Type 1 Diabetes: Is It Inevitable?

Barak M. Rosenn
1   Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Jersey City Medical Center, Jersey City, New Jersey
,
Jane C. Khoury
2   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
4   Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Francis Mimouni
5   Department of Pediatrics and Research Institute, Leumit Health Services, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Shelley Ehrlich
2   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
6   Department of Environmental and Public Health Sciences, University of Cincinnati, College of Medicine, Cincinnati, Ohio
,
Menachem Miodovnik
7   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Inova Health System, Fairfax, Virginia
› Institutsangaben Funding None.
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

The human body has abundant mechanisms to counteract hypoglycemia and prevent neuroglycopenia primarily involving the secretion of glucagon and adrenalin. Within several years from the onset of diabetes, people with type 1 diabetes lose their ability to mount a counterregulatory response to hypoglycemia and develop hypoglycemia unawareness, thus being at risk for deteriorating to a state of severe hypoglycemia and neuroglycopenia. Pregnant individuals with type 1 diabetes are particularly prone to experience severe hypoglycemia during the first half of pregnancy. This may be not only due to the institution of strict glycemic control and the nausea and vomiting prevalent during the early months of pregnancy, but also because the counterregulatory responses are further diminished during pregnancy. Severe hypoglycemia during early pregnancy does not appear to increase the risks of spontaneous abortion or congenital fetal malformations, but the potential long-term effects on the fetus are unknown. Recent technological advances have contributed to improved glycemic control and time in range as well as decreased risk of hypoglycemia in people with diabetes. These advances include treatment with insulin analogs, use of continuous glucose monitors, and closed-loop systems for administration of insulin. Limited studies have demonstrated that pregnant individuals with type 1 diabetes may also benefit from these modalities. While ongoing research continues to explore the adjustment of closed-loop systems for optimal use during pregnancy, more effort is needed to explore the optimal use of these modalities in pregnancy.

Key Points

  • People with type 1 diabetes have diminished counterregulatory responses to hypoglycemia and frequently develop hypoglycemia unawareness.

  • Pregnant individuals with type 1 diabetes are at increased risk for severe hypoglycemia particularly during the first half of pregnancy.

  • Use of insulin analogs and newer technologies for insulin administration may lower the risk of hypoglycemia in pregnant individuals with type 1 diabetes.

Keywords

hypoglycemia - diabetes - type 1 diabetes - counterregulatory hormones


Publikationsverlauf

Eingereicht: 10. April 2024

Angenommen: 15. Oktober 2024

Artikel online veröffentlicht:
27. November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Rayburn W, Piehl E, Jacober S, Schork A, Ploughman L. Severe hypoglycemia during pregnancy: its frequency and predisposing factors in diabetic women. Int J Gynaecol Obstet 1986; 24 (04) 263-268
    CrossrefPubMedSuche in Google Scholar
  • 2 Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies?. BMJ 1990; 301 (6760) 1070-1074
    CrossrefPubMedSuche in Google Scholar
  • 3 Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992; 15 (08) 1034-1037
    CrossrefPubMedSuche in Google Scholar
  • 4 Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000; 79 (11) 958-962
    CrossrefPubMedSuche in Google Scholar
  • 5 Evers IM, ter Braak EW, de Valk HW, van Der Schoot B, Janssen N, Visser GH. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002; 25 (03) 554-559
    CrossrefPubMedSuche in Google Scholar
  • 6 Rosenn B, Miodovnik M, Holcberg G, Jaekle RK, Khoury J, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy in insulin-dependent diabetes mellitus pregnancies. Obstet Gynecol 1995; 85: 417-422
    CrossrefPubMedSuche in Google Scholar
  • 7 Murphy HR, Rayman G, Duffield K. et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007; 30 (11) 2785-2791
    CrossrefPubMedSuche in Google Scholar
  • 8 Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004; 104 (01) 88-93
    CrossrefPubMedSuche in Google Scholar
  • 9 Mitrakou A, Ryan C, Veneman T. et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991; 260 (1 Pt 1): E67-E74
    PubMedSuche in Google Scholar
  • 10 Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987; 79 (03) 777-781
    CrossrefPubMedSuche in Google Scholar
  • 11 Cryer PE, Gerich JE. Hypoglycemia in insulin dependent diabetes mellitus: insulin excess and defective glucose counterregulation. In: Rifkin H, Porte D. eds. Ellenberg and Rifkin's Diabetes Mellitus. Theory and Practice, 4th ed. New York: Elsevier; 1990: 526-546
    Suche in Google Scholar
  • 12 White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983; 308 (09) 485-491
    CrossrefPubMedSuche in Google Scholar
  • 13 Boden G, Reichard Jr GA, Hoeldtke RD, Rezvani I, Owen OE. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med 1981; 305 (20) 1200-1205
    CrossrefPubMedSuche in Google Scholar
  • 14 Bolli G, de Feo P, Compagnucci P. et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983; 32 (02) 134-141
    CrossrefPubMedSuche in Google Scholar
  • 15 Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes 1992; 41 (03) 255-260
    CrossrefPubMedSuche in Google Scholar
  • 16 Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med 1985; 103 (02) 184-190
    CrossrefPubMedSuche in Google Scholar
  • 17 Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987; 316 (22) 1376-1383
    CrossrefPubMedSuche in Google Scholar
  • 18 Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37 (07) 901-907
    CrossrefPubMedSuche in Google Scholar
  • 19 Widom B, Simonson DC. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 1992; 41 (12) 1597-1602
    CrossrefPubMedSuche in Google Scholar
  • 20 Davis MR, Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 1991; 73 (05) 995-1001
    CrossrefPubMedSuche in Google Scholar
  • 21 Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 90 (04) 450-459
    CrossrefPubMedSuche in Google Scholar
  • 22 Connolly CC, Aglione LN, Smith MS, Lacy DB, Moore MC. Pregnancy impairs the counterregulatory response to insulin-induced hypoglycemia in the dog. Am J Physiol Endocrinol Metab 2004; 287 (03) E480-E488
    CrossrefPubMedSuche in Google Scholar
  • 23 Diamond MP, Reece EA, Caprio S. et al. Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1992; 166 (1 Pt 1): 70-77
    CrossrefPubMedSuche in Google Scholar
  • 24 Rosenn BM, Miodovnik M, Khoury JC, Siddiqi TA. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996; 87 (04) 568-574
    CrossrefPubMedSuche in Google Scholar
  • 25 Ellington SK. Development of rat embryos cultured in glucose-deficient media. Diabetes 1987; 36 (12) 1372-1378
    CrossrefPubMedSuche in Google Scholar
  • 26 Hunter III ES, Sadler TW. Fuel-mediated teratogenesis: biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro. Am J Physiol 1989; 257 (2 Pt 1): E269-E276
    PubMedSuche in Google Scholar
  • 27 Akazawa M, Akazawa S, Hashimoto M. et al. Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes 1989; 38 (12) 1573-1578
    CrossrefPubMedSuche in Google Scholar
  • 28 Buchanan TA, Sipos GF. Lack of teratogenic effect of brief maternal insulin-induced hypoglycemia in rats during late neurulation. Diabetes 1989; 38 (08) 1063-1066
    CrossrefPubMedSuche in Google Scholar
  • 29 Impastato DJ, Gabriel AR, Lardaro HH. Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 1964; 25: 542-546
    PubMedSuche in Google Scholar
  • 30 Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 1991; 265 (06) 731-736
    CrossrefPubMedSuche in Google Scholar
  • 31 Mills JL, Knopp RH, Simpson JL. et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988; 318 (11) 671-676
    CrossrefPubMedSuche in Google Scholar
  • 32 Steel JM. Hypoglycemia and diabetic pregnancy. In: Frier B, Fisher M. eds. Hypoglycemia and Diabetes: Clinical and Physiological Aspects. London: Edward Arnold; 1993: 247
    Suche in Google Scholar
  • 33 Eriksson UJ, Dahlström VE, Lithell HO. Diabetes in pregnancy: influence of genetic background and maternal diabetic state on the incidence of skeletal malformations in the fetal rat. Acta Endocrinol Suppl (Copenh) 1986; 277: 66-73
    PubMedSuche in Google Scholar
  • 34 Confino E, Ismajovich B, David MP, Gleicher N. Fetal heart rate in maternal hypoglycemic coma. Int J Gynaecol Obstet 1985; 23 (01) 59-60
    CrossrefPubMedSuche in Google Scholar
  • 35 Matias A, Xavier P, Bernardes J, Patrício B. Fetal heart-rate monitoring during maternal hypoglycaemic coma: a case report. Eur J Obstet Gynecol Reprod Biol 1998; 79 (02) 223-225
    CrossrefPubMedSuche in Google Scholar
  • 36 Langer O, Cohen WR. Persistent fetal bradycardia during maternal hypoglycemia. Am J Obstet Gynecol 1984; 149 (06) 688-690
    CrossrefPubMedSuche in Google Scholar
  • 37 Stangenberg M, Persson B, Stånge L, Carlström K. Insulin-induced hypoglycemia in pregnant diabetics. Maternal and fetal cardiovascular reactions. Acta Obstet Gynecol Scand 1983; 62 (03) 249-252
    CrossrefPubMedSuche in Google Scholar
  • 38 Reece EA, Hagay Z, Roberts AB. et al. Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women. Am J Obstet Gynecol 1995; 172 (1 Pt 1): 151-155
    CrossrefPubMedSuche in Google Scholar
  • 39 Björklund AO, Adamson UKC, Almström NHH. et al. Effects of hypoglycaemia on fetal heart activity and umbilical artery Doppler velocity waveforms in pregnant women with insulin-dependent diabetes mellitus. Br J Obstet Gynaecol 1996; 103 (05) 413-420
    CrossrefPubMedSuche in Google Scholar
  • 40 Holden KP, Jovanovic L, Druzin ML, Peterson CM. Increased fetal activity with low maternal blood glucose levels in pregnancies complicated by diabetes. Am J Perinatol 1984; 1 (02) 161-164
    Thieme ConnectPubMedSuche in Google Scholar
  • 41 Anderson Jr JH, Brunelle RL, Koivisto VA. et al; Multicenter Insulin Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46 (02) 265-270
    CrossrefPubMedSuche in Google Scholar
  • 42 Tricco AC, Ashoor HM, Antony J. et al. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ 2014; 349: g5459
    CrossrefPubMedSuche in Google Scholar
  • 43 Bartley PC, Bogoev M, Larsen J, Philotheou A. Long-term efficacy and safety of insulin detemir compared to neutral protamine Hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med 2008; 25 (04) 442-449
    CrossrefPubMedSuche in Google Scholar
  • 44 Mathiesen ER, Kinsley B, Amiel SA. et al; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30 (04) 771-776
    CrossrefPubMedSuche in Google Scholar
  • 45 Mathiesen ER, Hod M, Ivanisevic M. et al; Detemir in Pregnancy Study Group. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012; 35 (10) 2012-2017
    CrossrefPubMedSuche in Google Scholar
  • 46 ElSayed NA, Aleppo G, Aroda VR. et al; on behalf of the American Diabetes Association. Diabetes technology: standards of care in diabetes 2023. Diabetes Care 2023; 46 (Suppl. 01) S111-S127
    CrossrefPubMedSuche in Google Scholar
  • 47 Battelino T, Danne T, Bergenstal RM. et al. Clinical standards for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42 (08) 1593-1603
    CrossrefPubMedSuche in Google Scholar
  • 48 Feig DS, Donovan LE, Corcoy R. et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017; 390 (10110): 2347-2359
    CrossrefPubMedSuche in Google Scholar
  • 49 Coustan DR, Reece EA, Sherwin RS. et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 1986; 255 (05) 631-636
    CrossrefPubMedSuche in Google Scholar
  • 50 Carta Q, Meriggi E, Trossarelli GF. et al. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Diabete Metab 1986; 12 (03) 121-129
    PubMedSuche in Google Scholar
  • 51 Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000; 182 (06) 1283-1291
    CrossrefPubMedSuche in Google Scholar
  • 52 Lapolla A, Dalfrà MG, Masin M. et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003; 40 (03) 143-149
    CrossrefPubMedSuche in Google Scholar
  • 53 Tundidor D, Meek CL, Yamamoto J. et al; CONCEPTT Collaborative Group. Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes. Diabetes Technol Ther 2021; 23 (10) 710-714
    CrossrefPubMedSuche in Google Scholar
  • 54 Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 2017; 5 (07) 501-512
    CrossrefPubMedSuche in Google Scholar
  • 55 Bekiari E, Kitsios K, Thabit H. et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 2018; 361: k1310
    CrossrefPubMedSuche in Google Scholar
  • 56 Murphy HR, Elleri D, Allen JM. et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011; 34 (02) 406-411
    CrossrefPubMedSuche in Google Scholar
  • 57 Stewart ZA, Wilinska ME, Hartnell S. et al. Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 2016; 375 (07) 644-654
    CrossrefPubMedSuche in Google Scholar
  • 58 Stewart ZA, Wilinska ME, Hartnell S. et al. Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care 2018; 41 (07) 1391-1399
    CrossrefPubMedSuche in Google Scholar
  • 59 Polsky S, Akturk HK. Case series of a hybrid closed-loop system used in pregnancies in clinical practice. Diabetes Metab Res Rev 2020; 36 (03) e3248
    CrossrefPubMedSuche in Google Scholar
  • 60 Ozaslan B, Levy CJ, Kudva YC. et al. Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm. Diabetes Technol Ther 2022; 24 (07) 471-480
    CrossrefPubMedSuche in Google Scholar
  • 61 Levy CJ, Kudva YC, Ozaslan B. et al; LOIS-P Diabetes and Pregnancy Consortium. At-home use of a pregnancy-specific zone-MPC closed-loop system for pregnancies complicated by type 1 diabetes: a single-arm observational multicenter study. Diabetes Care 2023; 46 (07) 1425-1431
    CrossrefPubMedSuche in Google Scholar
  • 62 Lee TTM, Collett C, Bergford S. et al; AiDAPT Collaborative Group. Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med 2023; 389 (17) 1566-1578
    CrossrefPubMedSuche in Google Scholar